Updated:
NKGen Biotech, Inc.
NKGen Biotech, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001845459, and its reported industry is...
Overview
NKGen Biotech, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001845459, and its reported industry is Biological Products, (No Diagnostic Substances). In 10-K filed on 2025-10-08, it reported net income of USD -44,286,000; total assets of USD 16,231,000 for the fiscal period ended 2024-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- NKGen Biotech, Inc.
- Former names in filing history
- Graf Acquisition Corp. IV (2021-02-23 to 2023-09-29)
- Classification
- Company
- Industry (SIC)
- 2836 — Biological Products, (No Diagnostic Substances)
- Headquarters
- Santa Ana, CA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001845459
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2024USD | — | -$44.3M | $16.2M | $106,000 | -$20.9M | |
| FY2023USD | $0 | -$83.0M | $16.5M | $26,000 | -$21.9M | |
| FY2022USD | — | $4.5M | $174.4M | $635,155 | -$1.6M |
FY2022. Net income, Total assets, Cash and equivalents, Operating cash flow: shown as originally filed; later filings report different values for the same periods.
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | CURRENT REPORT | ||
| 8-K | CURRENT REPORT | ||
| 8-K | CURRENT REPORT | ||
| 8-K | CURRENT REPORT | ||
| 8-K | CURRENT REPORT | ||
| 8-K | CURRENT REPORT | ||
| 8-K | CURRENT REPORT | ||
| 8-K | CURRENT REPORT | ||
| 8-K | CURRENT REPORT | ||
| 10-Q | 10-Q | ||
| 8-K | CURRENT REPORT | ||
| 8-K | CURRENT REPORT |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research NKGen Biotech, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.